Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil R Cashman

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Current Drug Metabolism|April 8, 2003
Induced adaptive resistance to oxidative stress in the CNS: a discussion on possible mechanisms and their therapeutic potentialAmy Bishop, Neil R Cashman
Nature Reviews. Drug Discovery|October 2, 2004
Prion diseases--close to effective therapy?Neil R Cashman, Byron Caughey
Muscle & Nerve|December 16, 2004
Post-poliomyelitis syndromeDaria A Trojan, Neil R Cashman
The Journal of Biological Chemistry|August 6, 2002
Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like formWen-Quan Zou, Neil R Cashman
Expert Opinion on Biological Therapy|February 16, 2005
Progress in prion vaccines and immunotherapiesJennifer K Griffin, Neil R Cashman
Handbook of Clinical Neurology|June 12, 2018
Prion-like mechanisms in amyotrophic lateral sclerosisJacob I Ayers, Neil R Cashman
Prion|January 8, 2014
Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosisLeslie I Grad, Neil R Cashman
Ebiomedicine|September 6, 2020
Selenium-based compounds: Emerging players in the ever-unfolding story of SOD1 in amyotrophic lateral sclerosisJustin J Yerbury, Neil R Cashman
Prion|May 29, 2012
A special focus issue on the materials of Prion 2011 meeting in Montreal, CanadaNeil R Cashman, Yury O Chernoff
Neurobiology of Disease|July 20, 2020
Passive immunotherapies targeting Aβ and tau in Alzheimer's diseaseSteven S Plotkin, Neil R Cashman
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Current Drug Metabolism|April 8, 2003
Induced adaptive resistance to oxidative stress in the CNS: a discussion on possible mechanisms and their therapeutic potentialAmy Bishop, Neil R Cashman
Nature Reviews. Drug Discovery|October 2, 2004
Prion diseases--close to effective therapy?Neil R Cashman, Byron Caughey
Muscle & Nerve|December 16, 2004
Post-poliomyelitis syndromeDaria A Trojan, Neil R Cashman
The Journal of Biological Chemistry|August 6, 2002
Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like formWen-Quan Zou, Neil R Cashman
Expert Opinion on Biological Therapy|February 16, 2005
Progress in prion vaccines and immunotherapiesJennifer K Griffin, Neil R Cashman
Handbook of Clinical Neurology|June 12, 2018
Prion-like mechanisms in amyotrophic lateral sclerosisJacob I Ayers, Neil R Cashman
Prion|January 8, 2014
Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosisLeslie I Grad, Neil R Cashman
Ebiomedicine|September 6, 2020
Selenium-based compounds: Emerging players in the ever-unfolding story of SOD1 in amyotrophic lateral sclerosisJustin J Yerbury, Neil R Cashman
Prion|May 29, 2012
A special focus issue on the materials of Prion 2011 meeting in Montreal, CanadaNeil R Cashman, Yury O Chernoff
Neurobiology of Disease|July 20, 2020
Passive immunotherapies targeting Aβ and tau in Alzheimer's diseaseSteven S Plotkin, Neil R Cashman
Pageof 12